REGULATORY FOCUS – New reports address generics pricing, innovation in the EU

Supply crunch for essential cancer medicines shows the… 16 February 2022 Reports of supply shortages of breast cancer medicine (Tamoxifen) in…
A streamlined, digital regulatory framework is the… 27 September 2023 The off-patent medicines sector accounts for almost 70% of medicines…
One- Pager: New pricing models for generic medicines 10 October 2022 How can we ensure a sustainable healthcare system while safeguarding…
EURACTIV - Adjust prices to save drugs, generics industry… 6 February 2023 The generics industry is urging EU and national governments to…